Isis Pharmaceuticals is an antisense drug discovery technology company developing therapies for a number of serious diseases. Read the full story

Discovery stage partnering refers to a commercial deal or alliance signed when two... Read the full story

FOB Synthesis has entered into a research and development option and license agreement with AstraZeneca for the development of a novel antibiotic to treat drug-resistant bacterial infections. Read the full story

German healthcare group Merck KGaA is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said. Read the full story

Genentech has entered into biotech deals with Arrayit to purchase a drug discovery tool for $138,000. Read the full story

Johnson & Johnson is joining the hunt for drugs to treat dengue fever - the world's fastest-spreading tropical disease - by entering pharma deals with academic researchers in Belgium and the Wellcome Trust medical charity. Read the full story

The Myelin Repair Foundation has granted a non-exclusive sublicense to Biogen Idec, as part of their pharma deals, for the use of MRF’s technologies to generate a novel mouse model for all demyelinating diseases, including multiple sclerosis. Read the full story

FORMA Therapeutics announced a strategic collaboration, co-promotion and option agreement with Celgene Corporation under which FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets. Read the full story

Big pharma company, AstraZeneca, pharma partners Alchemia for multi-target, drug discovery collaboration. Read the full story

Read the full story